Drug

Pfizer Projects $33 Billion in COVID Vaccine Revenues, Driven by Boosters and Vaccines for Kids

Pfizer hiked its projections for COVID vaccine revenues, telling investors this week it expects booster shots, a vaccine targeting the Delta variant and anticipated authorization of its vaccines for children as young as 6 months will drive revenues higher.

Ivermectin ‘Safe,’ ‘Effective’ COVID Treatment: WSJ Op-Ed

A Wall Street Journal op-ed claims the FDA is "attacking a safe, effective drug," Ivermectin, even though the FDA itself certified the medication in 1996.

Half of Fauci’s Own Organization Reject the COVID ‘Vaccine’

Dr. Anthony Fauci—Director of the U.S. National Institute of Allergy and Infectious Diseases (NIAID)—testified before the Senate that only "a little bit more than half" of the employees working under him have been vaccinated.

Pfizer’s COVID Vaccine Could Become Most Lucrative Drug in the World

Pfizer’s vaccine is already the second-highest revenue-generating drug in the world. Once the pandemic ends, the vaccine maker plans to hike prices.

Latest news

- Advertisement -spot_img